These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26885026)

  • 1. Deregulation of decorin and FHL1 are associated with esophageal squamous cell carcinoma progression and poor prognosis.
    Ji C; Liu H; Xiang M; Liu J; Yue F; Wang W; Chu X
    Int J Clin Exp Med; 2015; 8(11):20965-70. PubMed ID: 26885026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma.
    Wei Q; Li X; Zhu Z; Yu W; Qin G; Chen H; Gu Y; Zhao K; Fu X; Sun M
    Pathol Res Pract; 2019 Dec; 215(12):152645. PubMed ID: 31704154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
    Yang Z; Cui Y; Ni W; Kim S; Xuan Y
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin α5 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.
    Xie JJ; Guo JC; Wu ZY; Xu XE; Wu JY; Chen B; Ran LQ; Liao LD; Li EM; Xu LY
    Hum Pathol; 2016 Feb; 48():69-75. PubMed ID: 26772401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
    Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
    Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
    Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
    Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
    Lin X; Xu XY; Chen QS; Huang C
    Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Liu Z; Yang T; Xu Z; Cao X
    Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
    He Z; Yi J; Jin L; Pan B; Chen L; Song H
    Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
    Zhao X; Tang YP; Wang CY; Wu JX; Ye F
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 expression on tumor cells associated with favorable prognosis in surgically resected esophageal squamous cell carcinoma.
    Guo W; Zhang F; Shao F; Wang P; Li Z; Yang X; He Z; Shi S; Gao Y; He J
    Hum Pathol; 2019 Feb; 84():291-298. PubMed ID: 30296523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
    Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
    Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between 5-lipoxygenase expression, and malignant behaviors and poor prognosis in esophageal squamous cell carcinoma.
    Bai CY; Zhang JY; Shi TW; Bai YQ; Wu BL; Du ZP; Wu ZY; Xu XE; Wang SH; Wu JY; Te RY; Zhang JY; Xu LY; Li EM
    Oncol Lett; 2018 Jun; 15(6):9353-9360. PubMed ID: 29805660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
    Deng F; Zhou K; Cui W; Liu D; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.